• Users Online: 214
  • Print this page
  • Email this page

 Table of Contents  
Year : 2020  |  Volume : 58  |  Issue : 2  |  Page : 134-135

COVID Journal review

Department of Cornea, RIO GOH, Chennai, Tamil Nadu, India

Date of Submission29-Apr-2020
Date of Acceptance01-May-2020
Date of Web Publication17-Jun-2020

Correspondence Address:
Dr. Nivetha Gandhi
Department of Cornea, RIO GOH, Chennai, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjosr.tjosr_46_20

Rights and Permissions

How to cite this article:
Gandhi N. COVID Journal review. TNOA J Ophthalmic Sci Res 2020;58:134-5

How to cite this URL:
Gandhi N. COVID Journal review. TNOA J Ophthalmic Sci Res [serial online] 2020 [cited 2022 Dec 7];58:134-5. Available from: https://www.tnoajosr.com/text.asp?2020/58/2/134/286937

  Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (Covid-19) Patients Top

Seah IY, Anderson DE, Kang AE, Wang L, Rao P, Young BE, Lye DC, Agrawal R. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology 2020; S0161-6420(20)30311-0. [doi: 10.1016/j.ophtha.2020.03.026]

Aim: To assess the viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients whether nasolacrimal system can act as a conduit for viruses to travel from the upper respiratory tract to the eye. Methods: Seventeen COVID-19 patients were recruited for this prospective study in Singapore. The COVID-19 patients showed positive results by reverse transcriptase–polymerase chain reaction (RT-PCR) of the nasopharyngeal swab samples in a clinical diagnostic laboratory. Nasopharyngeal swab samples from them were collected in a universal viral transport medium, and RNA extraction was carried out using RT-PCR analysis. Tears were sampled using a Schirmer test strip at varying time points between 3 and 20 days after the initial development of symptoms. Samples from both eyes were obtained and analyzed separately. Samples were delivered to a research laboratory for processing in the universal transport media for RT-PCR analysis of viral RNA. Samples were also inoculated into Vero-E6 cells and observed for the presence of cytopathic effect. A total of 64 samples were obtained over the study period, with 12, 28, and 24 samples obtained from the 1st, 2nd, and 3rd week of initial symptoms, respectively. Results: The results showed no evidence of SARS-CoV-2 shedding in tears throughout the course of the disease. Only one patient showed ocular symptoms during the disease course, and no evidence of SARS-CoV-2 could be found in tear samples. Limitations: First, the samples were analyzed in different laboratories using two different assays. Second, only tears were sampled, rather than conjunctival tissue to reduce patient distress in a pandemic. Third, the study had a small sample size because of the logistical limitations of the outbreak response. Conclusion: The results from the study suggest that the risk of SARS-CoV-2 transmission through tears is low. However, further definitive mechanistic studies are required.

  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (Covid-19) in Hubei Province, China Top

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020.

Aim: To investigate ocular manifestations and viral prevalence in the conjunctiva of patients with COVID-19. Methods: Thirty-eight consecutive patients with COVID-19 were recruited. The patient symptoms, ocular manifestations, chest computed tomographic scans, and results of blood tests and RT-PCR from the nasopharyngeal and conjunctival swabs for SARS-CoV-2 were noted and analyzed. Results: Among the 38 patients, 28 had positive findings for COVID-19 on RT-PCR from the nasopharyngeal swabs, and of these, two patients yielded positive findings in their conjunctival as well as nasopharyngeal specimens. A total of 12 of 38 patients had ocular manifestations consistent with conjunctivitis. Limitations: First, the study includes a relatively small sample size. Second, the sampling was made only once from the eye which can decrease the prevalence owing to false negatives. Conclusion: In this study, one-third of the patients with COVID-19 had ocular abnormalities, which frequently occurred in patients with more severe COVID-19. Although there is a low prevalence of SARS-CoV-2 in tears, it is possible to transmit via the eyes.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Assessing Viral ...
Characteristics ...

 Article Access Statistics
    PDF Downloaded110    
    Comments [Add]    

Recommend this journal